NCT01853631
- Conditions
- Acute Lymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +20 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Clinical trial condition
Acute Lymphocytic Leukemia
Explore clinical trials studying Acute Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
81 public trials
13 recruiting studies
Acute Lymphocytic Leukemia trial results
NCT07008885
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- China Beijing, Biotherapeutic Department of Chinese PLA General Hospital, China
- China Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital, China
Recruiting
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
NCT06783816
- Conditions
- Acute Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Shanxi Bethune Hospital Taiyuan, Shanxi, China
Not yet recruiting
Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)
NCT07371533
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
Active, not recruiting
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
NCT06476665
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Pfizer Tokyo, Japan
Active, not recruiting
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
NCT05044039
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Active, not recruiting
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
NCT01430390
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, not recruiting
Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
NCT05456698
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Active, not recruiting
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
NCT00586391
- Conditions
- Acute Lymphocytic Leukemia, B Cell Lymphoma, Chronic Disease, +20 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, not recruiting
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT03674411
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +48 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States